Petra Tesch
Keine laufenden Positionen mehr
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Annette Clancy | F | 70 | 10 Jahre | |
Thure Bo Thomas Thuresson | M | 67 | 6 Jahre | |
Helena Ildiko Saxon | F | 54 | 13 Jahre | |
Annikki Schaeferdiek | F | 55 | 7 Jahre | |
Erik Johan Malmberg | M | 42 | 4 Jahre | |
Jonas Johan Fredrik Hasselberg | M | 57 | 6 Jahre | |
Asa Regen Jansson | M | 54 | 1 Jahre | |
Sven Martin Vilhelm Gren | M | 62 | 7 Jahre | |
Anna Maria Inga Söderblom | M | 61 | 2 Jahre | |
Madeleine Samuelson | F | 52 | 2 Jahre | |
Magnus Lönn | M | 50 | 2 Jahre | |
Paul de Freene | M | 55 | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Wenche Nelly A. Rolfsen Sandsborg | M | 72 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 8 Jahre |
Wills Hughes-Wilson | F | 53 | 6 Jahre | |
Carl Johan Kördel | M | 62 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 Jahre |
Mats Gunnar Pettersson | M | 78 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 Jahre |
Jan Anders Jonas Persson | M | 52 | 22 Jahre | |
Johannes G. C. P. Schikan | M | 66 | 9 Jahre | |
Jason Clark | M | 51 | 2 Jahre | |
Kennet Rooth | M | 69 | - | |
Cameron McDonough | M | 53 | 6 Jahre | |
Matthew Gantz | M | 59 | - | |
Linda Alexandra Höljö | F | 52 | 3 Jahre | |
Helge Martin Ödman | M | 67 | 19 Jahre | |
Paul Bates | M | 49 | 12 Jahre | |
Pia Magnhild Helena Gideon | F | 70 | - | |
Eva Maria Cecilia S. Elmstedt | F | 64 | 13 Jahre | |
Adine Charlotte Grate Axén | F | 63 | - | |
Nils Anders Hultmark | M | 70 | 13 Jahre | |
Erling Lennart Johansson | M | 69 | - | |
Alf Gunnar Martin Nicklasson | M | 69 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 3 Jahre |
Thomas Kronen | M | - | - | |
Stephen James | M | 58 | 8 Jahre | |
Birgitte Volck | M | 61 | 4 Jahre | |
Rami Levin | M | 55 | - | |
Annika Muskantor | F | 58 | 1 Jahre | |
Hege Hellstrom | M | 59 | 5 Jahre | |
Dennis Schmidt Pedersen | M | 54 | - | |
Philip Wood | M | 56 | 9 Jahre | |
Krassimir Mitchev | M | - | 5 Jahre | |
Frits Wibbelink | M | - | 6 Jahre | |
Kirsti Gjellan | M | 61 | 5 Jahre | |
Ann-Charlotte Arnshav | F | 56 | 2 Jahre | |
Sara Ossborn | F | 52 | 2 Jahre | |
Eirik Pedersen | M | 60 | 3 Jahre | |
Markus Thor | M | 53 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 8 Jahre |
Lars Sandström | M | 52 | 2 Jahre | |
Anders Petter von Essen Thulin | M | 61 | - | |
Maarten van Unen | M | 45 | 5 Jahre | |
Peter Sellei | M | 64 | 1 Jahre | |
Andrea Conrad | F | - | - | |
Peder Sven Walberg | M | 50 | 1 Jahre | |
Åsa Stenqvist | F | 77 | - | |
Carin Dahlquist | F | - | - | |
Hans Glemstedt | M | 62 | 2 Jahre | |
Håkan Åström | M | 77 | 9 Jahre | |
Terje Kalland | M | 73 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 3 Jahre |
Kjell Rudolf Peter Edman | M | 70 | 3 Jahre | |
Paul de Potocki | M | 62 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 5 Jahre |
Sven Håkan Björklund | M | 68 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 Jahre |
Mats-Olof Ljungquist | M | 72 | 3 Jahre | |
Charlotta Ljungqvist | M | 63 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 Jahre |
Alan Henry Raffensperger | M | 64 | 5 Jahre | |
Margit Mahlapuu | M | 52 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 2 Jahre |
Jason G. Duncan | M | 50 | 1 Jahre | |
Marek Poszepczynski | M | - |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 6 Jahre |
Erik Kinnman | M | 66 | 3 Jahre | |
Michael Steinmetz | M | 75 | 10 Jahre | |
Catarina Larsson | F | 72 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 9 Jahre |
Bo-Gunnar Rosenbrand | M | 61 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | 9 Jahre |
Arne Kungberg | M | 61 | 26 Jahre | |
Mats-Olof Wallin | M | 73 | 5 Jahre | |
Karin Möllborg | F | - | 3 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweden | 73 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Petra Tesch
- Persönliches Netzwerk